PT - JOURNAL ARTICLE AU - Al-Dujaily, Hashem M. AU - Hussein, Huda A. AU - Abdelrahim, Bahaa AU - Shawer, Mohammad AU - Mehyar, Ahmad AU - Aljeradat, Baha’ AU - Batarseh, Dima AU - Khraim, Sarah AU - Abdeen, Amjad AU - Almaani, Noor TI - Validity and reliability of the Arabic version of topical corticosteroid phobia (TOPICOP<sup>©</sup>) questionnaire AID - 10.15537/smj.2025.46.3.20240506 DP - 2025 Mar 01 TA - Saudi Medical Journal PG - 307--315 VI - 46 IP - 3 4099 - http://smj.org.sa/content/46/3/307.short 4100 - http://smj.org.sa/content/46/3/307.full SO - Saudi Med J2025 Mar 01; 46 AB - Objectives: To translate the topical corticosteroid phobia (TOPICOP) scale into Arabic and assess its validity, reliability, and feasibility.Methods: A cross-sectional study was carried out at Jordan University Hospital, Amman, Jordan, in 2 phases. Phase one involved translation of the TOPICOP scale into Arabic using a 2-step process, followed by pilot testing and content validation by 6 bilingual dermatologists. Phase 2 involved subsequent validation and feasibility testing on a larger sample of 145 participants. To assess reliability, the scale was administered twice for test-retest analysis.Results: Calculated content validity indices revealed satisfactory values, establishing content validation of the Arabic version. Cronbach’s alpha coefficient indicated reliable internal consistency (0.757). Test-retest reliability yielded a Pearson’s correlation coefficient of 0.775 (p&lt;0.001). The mean global TOPICOP score was 56.4%. The scale was clear, feasible, and completed in under 5 minutes without difficulty.Conclusion: The Arabic TOPICOP scale is a valid, reliable, and effective tool for assessing corticosteroid phobia in Arabic-speaking populations. Its implementation can enhance understanding of patient adherence and improve eczema treatment outcomes, benefiting healthcare providers, including dermatologists, general practitioners, and family physicians.